Section 216(a) of the Protecting Access to Medicare Act of 2014 (PAMA)(PL 113-93); payment, coding and coverage for laboratory tests
Crosswalk payment for BRCA CPT codes
Coverage for personalized medicine tests for the treatment of major depressive disorder Regulation of laboratory developed tests - discussion draft in House - The Diagnostic Accuracy and Innovation Act (DAIA) and Verifying Accurate Leading-edge IVCT Development Act of 2018 (VALID); no HR # Potential legislation to amend statute governing patent eligibility; section 101
MMM - Medicare/Medicaid MED - Medical/Disease Research/Clinical Labs CPT - Copyright/Patent/Trademark
136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
MYRIAD GENETICS, INC.
1325 G Street NW STE 500, Washington, DC, 20005, US
KIMBERLY LINTHICUM (Leg Director, Rep Bob Franks (1197-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996)) KIMBERLY LINTHICUM (Leg Director, Rep Bob Franks (1997-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996)) KIMBERLY LINTHICUM (Leg Director, Rep Bob Franks (1997-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996))
Leg Director, Rep Bob Franks (1197-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996) Leg Director, Rep Bob Franks (1997-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996) Leg Director, Rep Bob Franks (1997-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996)